Belite Bio BLTE
NASDAQ BLTE
$153.43 -1.02 (-0.66%)
As of: Oct 21, 2026 · 3:59 PM EDT

Belite Bio (BLTE) Cash from Operations (2024 - 2025)

Updated

Belite Bio (BLTE) recorded Cash from Operations of -$10.39 million in Q4 2025, compared with -$4.6 million a year earlier.

Analysis

Belite Bio (BLTE) Cash from Operations (2024 - 2025) Analysis & Trends

For FY2025, Belite Bio reported Cash from Operations of -$36.99 million.

  • Across earlier years, Cash from Operations came in at -$29.23 million in FY2024, -$29.84 million in FY2023, -$11.46 million in FY2022 and -$7.47 million in FY2021.
  • The Q4 2025 figure is the lowest quarterly Cash from Operations since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 8.62 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 3.44 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.87 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 3.57 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 835.00 Mn
10 Belite Bio 5.16 Bn 5.16 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -10.39 Mn
Dec 31, 2024 -4.60 Mn
API Access

Belite Bio Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=BLTE&period=max&api_key=YOUR_API_KEY